PD

Peter Donnelly

ASSOCIATE VICE PRESIDENT FOR TECHNOLOGY PARTNERSHIPS at Stony Brook University

New York, New York

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $100,000.00
  • Target Investment:

    $100,000.00

Education

Work Experience

  • ASSOCIATE VICE PRESIDENT FOR TECHNOLOGY PARTNERSHIPS

    2019

    Lead all university innovation and technology commercialization efforts, including industry partnerships, the R&D Park, four Centers of Excellence and Advanced Technology, six startup incubators, and intellectual property development and licensing.

  • Director, Office of Technology Licensing and Industry Relationships

    2013 - 2019

    Innovation leader responsible for identification, development, and commercialization of promising early stage technologies across all fields through partnership with university scientists, industry, and the innovation ecosystem.

  • Managing Director

    2016

    The Accelerate NY Seed Fund invests in emerging scientific- and engineering-based new ventures in Downstate NY, most frequently founded on innovation at a research institution. By engaging high potential innovation at the very earliest stages of commercialization, Accelerate seeks to catalyze other investment, attract specialized expertise, and shape development plans to realize capital efficient outcomes sufficient to secure further funding.

  • Executive Director

    2016

    ALI is a non-profit economic development organization formed by Long Island's leading research institutions and business community to accelerate commercialization of scientific- and engineering-based innovation.

  • Deputy Director, Technology Development and Commercialization

    2012 - 2013

    Led identification, development, portfolio management, and commercialization of promising early stage technologies in energy, materials, high performance computing, and life sciences through partnership with Argonne scientists, industry, and the innovation ecosystem, including entrepreneurs and venture capital.

2011 - 2012

  • Innovation and Product Development, Practice Lead

    2011 - 2012

    Led practice in Innovation and Product Development with Global 2000 in Greater China. Lead the Quantum Leap Innovation Program, a new initiative to generate significant revenue and embed innovation in Accenture culture by building a concept-to-deployment portfolio of innovation projects.

  • Adjunct Faculty

    2008 - 2010

    Teach MBA course on strategic management of techology and innovation.

  • Associate Director, New Ventures and Business Development

    2007 - 2010

    Lead identification, development, and portfolio management of promising technologies and the spinout of some based on faculty, staff, and graduate student innovations.

2005 - 2007

  • CEO

    2005 - 2007

    Early stage biotech firm pioneering RNA trans-splicing therapeutics (HDL and LDL cholesterol, hemophilia A, monoclonal antibodies). Capital raised: $20M. Two pre-clinical programs. Large first-mover patent portfolio (40+). Led successful sale of company.

Jax, Inc

1998 - 2004

  • Co-Founder and Chief Operations Officer

    1998 - 2004

    Thin film technology venture with diverse applications in one-way imaging. Capital raised: $30M. Large first-mover patent portfolio (10+). Led acquisition of Italian firm. Grew to $10M in revenue and 25 employees.

1994 - 1998

  • Business and Finance Manager

    1994 - 1998

  • Associate Consultant

    1989 - 1992